U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation

Haratani, K; Yonesaka, K; Takamura, S; Maenishi, O; Kato, R; Takegawa, N; Kawakami, H; Tanaka, K; Hayashi, H; Takeda, M; Maeda, N; Kagari, T; Hirotani, K; Tsurutani, J; Nishio, K; Doi, K; Miyazawa, M; Nakagawa, K

Yonesaka, K (corresponding author), Kindai Univ, Fac Med, Dept Med Oncol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.

JOURNAL OF CLINICAL INVESTIGATION, 2020; 130 (1): 374

打开APP